Artículos de revistas sobre el tema "IDO/TDO"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "IDO/TDO".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Oweira, Hani, Imad Lahdou, Stefan Mehrle, Elias Khajeh, Rajan Nikbakhsh, Omid Ghamarnejad, Peter Terness, Christoph Reißfelder, Mahmoud Sadeghi y Ali Ramouz. "Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepG2 Tumor Cells". Journal of Clinical Medicine 11, n.º 16 (16 de agosto de 2022): 4794. http://dx.doi.org/10.3390/jcm11164794.
Texto completoTerai, Londin, Rochani, Link, Lam, Kaushal, Bhushan, Orloff y Sato. "Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma". Cancers 12, n.º 2 (10 de febrero de 2020): 405. http://dx.doi.org/10.3390/cancers12020405.
Texto completoKim, Chan, Joo Hoon Kim, Jin Sung Kim, Hong Jae Chon y Joo-Hang Kim. "A novel dual inhibitor of IDO and TDO, CMG017, potently suppresses the kynurenine pathway and overcomes resistance to immune checkpoint inhibitors." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): e14228-e14228. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14228.
Texto completoCampesato, Luis Felipe, Sadna Budhu, Jeremy Tchaicha, Abhinav Jaiswal, Mathieu Gigoux, Stephane Pourpe, Cailian Liu et al. "Blockade of IDO/TDO downstream effectors restricts cancer immune suppression". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 137.3. http://dx.doi.org/10.4049/jimmunol.202.supp.137.3.
Texto completoThackray, Sarah J., Christopher G. Mowat y Stephen K. Chapman. "Exploring the mechanism of tryptophan 2,3-dioxygenase". Biochemical Society Transactions 36, n.º 6 (19 de noviembre de 2008): 1120–23. http://dx.doi.org/10.1042/bst0361120.
Texto completoOxenkrug, G. "Genetic and Environmental Impacts in Major Depressive Disorder are Mediated Via Kynurenine Pathway of Tryptophan Metabolism". European Psychiatry 24, S1 (enero de 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70899-5.
Texto completoSUZUKI, Sachiko, Shigenobu TONÉ, Osamu TAKIKAWA, Toshikazu KUBO, Ichiro KOHNO y Yohsuke MINATOGAWA. "Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti". Biochemical Journal 355, n.º 2 (6 de abril de 2001): 425–29. http://dx.doi.org/10.1042/bj3550425.
Texto completoNienhaus, Karin y G. Ulrich Nienhaus. "Co Recombination in Human IDO and TDO - A Comparison". Biophysical Journal 106, n.º 2 (enero de 2014): 676a. http://dx.doi.org/10.1016/j.bpj.2013.11.3744.
Texto completoSacramento, Jireh Joy D. y David P. Goldberg. "Oxidation of an indole substrate by porphyrin iron(iii) superoxide: relevance to indoleamine and tryptophan 2,3-dioxygenases". Chemical Communications 56, n.º 20 (2020): 3089–92. http://dx.doi.org/10.1039/c9cc10019a.
Texto completoPaccosi, Sara, Marta Cecchi, Angela Silvano, Sergio Fabbri y Astrid Parenti. "Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines". Journal of Cancer Research and Clinical Oncology 146, n.º 12 (10 de agosto de 2020): 3155–63. http://dx.doi.org/10.1007/s00432-020-03351-2.
Texto completoFunakoshi, Hiroshi, Masaaki Kanai y Toshikazu Nakamura. "Modulation of Tryptophan Metabolism, Promotion of Neurogenesis and Alteration of Anxiety-Related Behavior in Tryptophan 2,3-Dioxygenase-Deficient Mice". International Journal of Tryptophan Research 4 (enero de 2011): IJTR.S5783. http://dx.doi.org/10.4137/ijtr.s5783.
Texto completoBadawy, Abdulla A.-B. "Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects". International Journal of Tryptophan Research 10 (1 de enero de 2017): 117864691769193. http://dx.doi.org/10.1177/1178646917691938.
Texto completoYoshioka, Saeko, Tomonori Ikeda, Sogo Fukuchi, Yurika Kawai, Katsumi Ohta, Hisashi Murakami, Naohisa Ogo, Daisuke Muraoka, Osamu Takikawa y Akira Asai. "Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase". International Journal of Tryptophan Research 15 (enero de 2022): 117864692211384. http://dx.doi.org/10.1177/11786469221138456.
Texto completoBadawy, Abdulla A.-B. y Gilles J. Guillemin. "Species Differences in Tryptophan Metabolism and Disposition". International Journal of Tryptophan Research 15 (enero de 2022): 117864692211225. http://dx.doi.org/10.1177/11786469221122511.
Texto completoYeh, Syun-Ru, Ariel Lewis-Ballester y Shay Karkashon. "Comparative Studies of Human Indoleamine 2,3-Dioxygenase (IDO) and Tryptophan Dioxygenase (TDO)". Biophysical Journal 102, n.º 3 (enero de 2012): 467a. http://dx.doi.org/10.1016/j.bpj.2011.11.2560.
Texto completoTakkenkamp, Tim J., Mathilde Jalving, Frederik J. H. Hoogwater y Annemiek M. E. Walenkamp. "The immune tumour microenvironment of neuroendocrine tumours and its implications for immune checkpoint inhibitors". Endocrine-Related Cancer 27, n.º 9 (septiembre de 2020): R329—R343. http://dx.doi.org/10.1530/erc-20-0113.
Texto completoLuques, Lisandro, Ashby Kissoondoyal, Emily De Sousa, Paula Quaglietta, David Malkin, Stefano Cairo, Emilie Indersie y Reto Baertschiger. "Abstract 3539: Indoleamine-2,3-dioxygenase 2 (IDO-2) is expressed in hepatoblastoma cells and associated with metastatic state". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 3539. http://dx.doi.org/10.1158/1538-7445.am2023-3539.
Texto completoQin, Yanjie, Nanxi Wang, Xinlin Zhang, Xuemei Han, Xuejia Zhai y Yongning Lu. "IDO and TDO as a potential therapeutic target in different types of depression". Metabolic Brain Disease 33, n.º 6 (16 de julio de 2018): 1787–800. http://dx.doi.org/10.1007/s11011-018-0290-7.
Texto completoMuzik, O., F. John, S. Mittal y C. Juhasz. "P11.35 Fluorine-18-labeled PET radiotracers for imaging tryptophan uptake and metabolism in brain tumors". Neuro-Oncology 21, Supplement_3 (agosto de 2019): iii50—iii51. http://dx.doi.org/10.1093/neuonc/noz126.181.
Texto completoYe, Zixiang, Linxiu Yue, Jiachen Shi, Mingmei Shao y Tao Wu. "Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications". Journal of Cancer 10, n.º 12 (2019): 2771–82. http://dx.doi.org/10.7150/jca.31727.
Texto completoJovanovic, Filip, Kenneth D. Candido y Nebojsa Nick Knezevic. "The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents". International Journal of Molecular Sciences 21, n.º 17 (22 de agosto de 2020): 6045. http://dx.doi.org/10.3390/ijms21176045.
Texto completoNaismith, James H. "Tryptophan oxygenation: mechanistic considerations". Biochemical Society Transactions 40, n.º 3 (22 de mayo de 2012): 509–14. http://dx.doi.org/10.1042/bst20120073.
Texto completoAshoura, Norah E., Joseph D. Dekker, Todd Triplett, Kendra Garrison, John Blazeck, Christos Karamitros, Candice Lamb et al. "The Force Awakens: Illuminating the role of kynurenine in cancer progression and treatment." Journal of Immunology 200, n.º 1_Supplement (1 de mayo de 2018): 177.3. http://dx.doi.org/10.4049/jimmunol.200.supp.177.3.
Texto completoRafice, Sara A., Nishma Chauhan, Igor Efimov, Jaswir Basran y Emma Lloyd Raven. "Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase". Biochemical Society Transactions 37, n.º 2 (20 de marzo de 2009): 408–12. http://dx.doi.org/10.1042/bst0370408.
Texto completoBadawy, Abdulla A.-B. y Gilles Guillemin. "The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal". International Journal of Tryptophan Research 12 (enero de 2019): 117864691986897. http://dx.doi.org/10.1177/1178646919868978.
Texto completoOh, Angela. "Crystallization of heme dioxygenases IDO and TDO facilitates structure-based design of cancer immunology therapeutics". Acta Crystallographica Section A Foundations and Advances 76, a1 (2 de agosto de 2020): a45. http://dx.doi.org/10.1107/s0108767320099547.
Texto completoCampesato, Luis Felipe, Sadna Budhu, Jeremy Tchaicha, Stephane Pourpe, Cailian Liu, Mark G. Manfredi, Karen McGovern, Jedd D. Wolchok y Taha Merghoub. "Interaction between Kynurenine and the AhR is an effector mechanism of tumor immunosuppression and represents a potential immunotherapy target". Journal of Immunology 200, n.º 1_Supplement (1 de mayo de 2018): 177.5. http://dx.doi.org/10.4049/jimmunol.200.supp.177.5.
Texto completoAlan, Wise, Mcguinness E. Barry, Cowley M. Phillip, Trewick C. Sarah, Bevan Nicola, Szybut Clare y Brown J. Thomas. "ITOC2 – 013. In vitro kynurenine modulation by novel dual-acting and selective TDO and IDO inhibitors". European Journal of Cancer 51 (marzo de 2015): S5. http://dx.doi.org/10.1016/j.ejca.2015.01.026.
Texto completoYuasa, Hajime J. y Helen J. Ball. "Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes". Journal of Experimental Zoology Part B: Molecular and Developmental Evolution 324, n.º 2 (20 de febrero de 2015): 128–40. http://dx.doi.org/10.1002/jez.b.22608.
Texto completoBadawy, Abdulla A. B., Aryan M. A. Namboodiri y John R. Moffett. "The end of the road for the tryptophan depletion concept in pregnancy and infection". Clinical Science 130, n.º 15 (29 de junio de 2016): 1327–33. http://dx.doi.org/10.1042/cs20160153.
Texto completoEl-Zahabi, Mohamed Ayman ALy, Mostafa Youssef Abouzeid, Ibrahim H. Eissa y Mohamed S. Taghour. "DUAL INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) AND TRYPTOPHAN-2,3-DIOXYGENASE (TDO) AS ANTI-TUMOR IMMUNE MODULATORS". Al-Azhar Journal of Pharmaceutical Sciences 69, n.º 1 (1 de marzo de 2024): 38–61. http://dx.doi.org/10.21608/ajps.2024.360357.
Texto completoKim, C., N. K. Lee, J. S. Kim, W. R. Kim, D. H. Kim, D. J. Kim, J. S. Oh, S. K. Chang, J. W. Kim y H. J. Chon. "An oral dual inhibitor of IDO and TDO enhances anti-cancer immunity and synergizes with immune checkpoint blockade". Annals of Oncology 29 (octubre de 2018): viii416. http://dx.doi.org/10.1093/annonc/mdy288.039.
Texto completoLiu, Xiangdong, Niu Shin, Holly K. Koblish, Gengjie Yang, Qian Wang, Kathy Wang, Lynn Leffet et al. "Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity". Blood 115, n.º 17 (29 de abril de 2010): 3520–30. http://dx.doi.org/10.1182/blood-2009-09-246124.
Texto completoBrincks, Erik L., James Adams, Lifu Wang, Benjamin Turner, Agnieszka Marcinowicz, Jiyuan Ke, Michael Essmann et al. "Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1". Oncotarget 11, n.º 25 (23 de junio de 2020): 2438–61. http://dx.doi.org/10.18632/oncotarget.27646.
Texto completoBerthon, Céline, Michaela Fontenay, Selim Corm, Isabelle Briche, Michel Lhermitte y Bruno Quesnel. "Metabolites of Tryptophan Catabolism Are Elevated in Sera of Patients with Myelodysplastic Syndromes and Inhibit Hematopoietic Progenitor Amplification". Blood 120, n.º 21 (16 de noviembre de 2012): 3843. http://dx.doi.org/10.1182/blood.v120.21.3843.3843.
Texto completoPetrovic, Vladimir, Jamie Wong, Cedric E. Dos Santos, Richard Smith, Dan Fitzpatrick, Robert Loberg y Ariel Avilion. "IDO Pathway Analysis for Identifying Novel Biomarkers in Multiple Myeloma". Blood 132, Supplement 1 (29 de noviembre de 2018): 5572. http://dx.doi.org/10.1182/blood-2018-99-111392.
Texto completoBooth, Nicholas, Wells Brockbank, Samuel Oh y Karl Kingsley. "Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated". Journal of Molecular Pathophysiology 1, n.º 1 (2012): 29. http://dx.doi.org/10.5455/jmp.20120609040915.
Texto completoChen, Xiangli, Yuzhu Zang, Dujuan Li, Jianmin Guo, Yacai Wang, Yuqi Lin y Zhenghong Wei. "IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era". Medicine 99, n.º 21 (22 de mayo de 2020): e19883. http://dx.doi.org/10.1097/md.0000000000019883.
Texto completoStone, Trevor W. y Richard O. Williams. "Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface". Cancers 15, n.º 11 (24 de mayo de 2023): 2895. http://dx.doi.org/10.3390/cancers15112895.
Texto completoJovanovic, Filip, Aboorva Sudhakar y Nebojsa Nick Knezevic. "The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator". International Journal of Tryptophan Research 15 (enero de 2022): 117864692210992. http://dx.doi.org/10.1177/11786469221099214.
Texto completoNoakes, Rowland R. "Effects of Tranilast on the Urinary Excretion of Kynurenic and Quinolinic Acid under Conditions of L Tryptophan Loading". International Journal of Tryptophan Research 6 (enero de 2013): IJTR.S12797. http://dx.doi.org/10.4137/ijtr.s12797.
Texto completoKubacka, Justyna, Anna Stefańska y Grażyna Sypniewska. "Kynurenine pathway: the link between depressive disorders and inflammation". Postępy Higieny i Medycyny Doświadczalnej 74 (6 de agosto de 2020): 331–39. http://dx.doi.org/10.5604/01.3001.0014.3454.
Texto completoSpector, Sydney, Chunjing Wu, Dan Nguyen, George Theodore, Ashley Garcia, Lynn Feun, Niramol Savaraj y Medhi Wangpaichitr. "Abstract 2325: Targeting kynurenine pathway using novel IDO/TDO dual inhibitor (AT0174) to modulate tumor microenvironment in platinum resistant non-small cell lung cancer cancer: An immunometabolism compliment markers". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 2325. http://dx.doi.org/10.1158/1538-7445.am2022-2325.
Texto completoPal, Anasua, Philipp Zimmer, Dorothea Clauss, Martina E. Schmidt, Cornelia M. Ulrich, Joachim Wiskemann y Karen Steindorf. "Resistance Exercise Modulates Kynurenine Pathway in Pancreatic Cancer Patients". International Journal of Sports Medicine 42, n.º 01 (24 de julio de 2020): 33–40. http://dx.doi.org/10.1055/a-1186-1009.
Texto completoGiannakis, Marios, Haoxin Li, Chelsea Jin, Shuba Gopal, Kaushal Desai, Christine Horak, Megan Wind-Rotolo et al. "Metabolomic correlates of response in nivolumab-treated renal cell carcinoma and melanoma patients." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): 3036. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3036.
Texto completoPires, Ananda Staats, Shabarni Gupta, Sean A. Barton, Roshana Vander Wall, Vanessa Tan, Benjamin Heng, Jacqueline K. Phillips y Gilles J. Guillemin. "Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease". International Journal of Tryptophan Research 15 (enero de 2022): 117864692211260. http://dx.doi.org/10.1177/11786469221126063.
Texto completoPapadopoulos, Kyriakos, Michael Cecchini, Juanita S. Lopez, Dirk Jäger, Ki Young Chung, Michael Platten, Florian Prinz et al. "Abstract CT276: Preliminary analysis of pharmacokinetic (PK) and target engagement biomarkers from a first in human phase 1 study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964". Cancer Research 83, n.º 8_Supplement (14 de abril de 2023): CT276. http://dx.doi.org/10.1158/1538-7445.am2023-ct276.
Texto completoDawood, Shazia, Samina Bano y Abdulla Abu-Bakr Badawy. "Inflammation and serotonin deficiency in major depressive disorder: Molecular docking of antidepressant and antiinflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases". Bioscience Reports, 4 de mayo de 2022. http://dx.doi.org/10.1042/bsr20220426.
Texto completoGualdoni, Gisela S., Patricia V. Jacobo, Cristian M. Sobarzo, Cecilia V. Pérez, María E. Matzkin, Christian Höcht, Mónica B. Frungieri et al. "Role of indoleamine 2,3-dioxygenase in testicular immune-privilege". Scientific Reports 9, n.º 1 (4 de noviembre de 2019). http://dx.doi.org/10.1038/s41598-019-52192-8.
Texto completoOxenkrug, Gregory y Valeriya Navrotska. "Extension of life span by down-regulation of enzymes catalyzing tryptophan conversion into kynurenine: Possible implications for mechanisms of aging". Experimental Biology and Medicine, 10 de junio de 2023, 153537022311794. http://dx.doi.org/10.1177/15353702231179411.
Texto completo